Apply on Employer Site

Rhythm Pharmaceuticals Inc. · 2 weeks ago

Associate Director, Scientific Communications

Boston, MA

Full-time

Hybrid

Lead/Staff, Director/Executive

$160K/yr - $240K/yr

5+ years exp

Rhythm Pharmaceuticals Inc. is a global biopharmaceutical company focused on transforming the lives of patients with rare neuroendocrine diseases. They are seeking an experienced Associate Director of Scientific Communications to lead the strategic planning and execution of scientific publications and communications for their rare neuroendocrine portfolio across North America.

BiotechnologyPharmaceuticalTherapeutics

Responsibilities

Develop and implement a comprehensive scientific communications and publication strategy for rare neuroendocrine diseases, encompassing all approved and pipeline indications with focus on North America priorities

Lead the creation, review, and dissemination of high-quality scientific manuscripts, abstracts, posters, and presentations targeted at key US medical conferences and peer-reviewed journals in strong collaboration with Global Scientific Communications team

Serve as a scientific thought leader and subject matter expert on neuroendocrine disease biology ensuring scientific accuracy and relevance in all communications for cross-functional teams

Collaborate closely with Value and Evidence, Clinical development, Global Scientific Communications, Commercial, International teams and external partners to ensure alignment and integration of scientific messaging across functions and materials

Contribute to Global Scientific Platform development and serve as the North America representative on the Global Publication Planning team for strategic planning, and review of manuscripts and posters

Monitor emerging scientific literature, competitive landscape, and publication trends in neuroendocrine diseases to identify and leverage publication opportunities

Ensure all scientific communications adhere to industry codes, ethical standards, and regulatory requirements

Qualification

Advanced degreeScientific communications experiencePublication strategy developmentPublication guidelinesReviewing scientific materialsPublication management softwareInterpersonal skillsCollaboration skills

Required

Advanced degree (PhD, PharmD or equivalent) in a relevant scientific or medical discipline

At least 5+ years of experience across scientific communications and/or medical affairs functions within biotech, pharma, or medical communications agency

Proven track record of developing and executing publication strategies for complex therapeutic areas, preferably within rare diseases or oncology/neuroendocrine space

Strong ability to interpret and communicate complex clinical and translational data clearly and accurately

Extensive experience in writing, reviewing, and publishing scientific materials and the ability to appraise scientific literature and raw data critically for potential development of new publications

Experience managing external vendors and ensuring compliance with timelines and quality standards

Expertise in publication guidelines and industry standards, including Good Publication Practices, ICMJE requirements, and PhRMA guidelines

Knowledge of scientific, statistical, and research principles and guidelines

Experience with and knowledge of publication management software/tools and a demonstrated ability to seek out and learn new technology

Excellent interpersonal and communication skills, with demonstrated success collaborating in cross-functional teams

Ability to travel up to 30% of the time, in alignment with business needs

Preferred

Rare disease preferred

Familiarity with publication guidelines such as ICMJE, GPP, and PhRMA Code is strongly preferred

Benefits

A discretionary annual bonus may be available based on individual and company performance.

This role may be eligible for benefits and other compensation such as restricted stock units.

Company

Rhythm Pharmaceuticals Inc.

Rhythm Pharmaceuticals is a global, commercial-stage biopharmaceutical company focused on transforming the lives of patients with rare neuroendocrine diseases by rapidly advancing care and precision medicines that address the root cause.

Founded in 2010

Boston, Massachusetts, USA

201-500 employees